Home > Brain Waves
About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
NEUROTECH REPORT
120_NIR09cover15.jpg 2009 Industry Report Available
NEUROTECH NEWS
NEUROTECH INDEX
INDUSTRY REPORT 2008
INVESTMENT NEWSLETTERS
BLOGS I READ
HealthBlog
Neurodudes
Mind Hacks
Neuro-journalism Mill
Neurolearning
Ross Mayfield
Future Pundit
Marginal Revolution
Pat Kane
Pipeline
Virginia Postrel
Brad Delong - Econ
Business Pundit
RECENT ENTRIES

November 2009 (1)
October 2009 (4)
September 2009 (4)
August 2009 (6)
July 2009 (7)
June 2009 (7)
May 2009 (5)
April 2009 (3)
March 2009 (4)
February 2009 (5)
January 2009 (6)
December 2008 (3)
November 2008 (5)
October 2008 (3)
September 2008 (3)
August 2008 (5)
July 2008 (4)
June 2008 (9)
May 2008 (11)
April 2008 (5)
March 2008 (1)
February 2008 (6)
January 2008 (3)
December 2007 (4)
November 2007 (5)
October 2007 (8)
September 2007 (6)
August 2007 (8)
July 2007 (6)
June 2007 (4)
May 2007 (4)
April 2007 (5)
March 2007 (5)
February 2007 (8)
January 2007 (6)
December 2006 (6)
November 2006 (8)
October 2006 (3)
September 2006 (9)
August 2006 (8)
July 2006 (13)
June 2006 (11)
May 2006 (8)
April 2006 (11)
March 2006 (10)
February 2006 (7)
January 2006 (10)
December 2005 (6)
November 2005 (21)
October 2005 (15)
September 2005 (15)
August 2005 (12)
July 2005 (15)
June 2005 (15)
May 2005 (16)
April 2005 (3)
March 2005 (15)
February 2005 (19)
January 2005 (19)
December 2004 (8)
November 2004 (9)
October 2004 (8)
September 2004 (11)
August 2004 (11)
July 2004 (20)
June 2004 (14)
May 2004 (17)
April 2004 (21)
March 2004 (33)
February 2004 (17)
January 2004 (13)
December 2003 (17)
November 2003 (19)
October 2003 (21)
September 2003 (22)
August 2003 (15)
July 2003 (26)
June 2003 (20)
May 2003 (21)
April 2003 (24)
March 2003 (25)
February 2003 (5)



Subscribe with Bloglines
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline


Brain Waves
September 27, 2004
ADHD - NeuroImaging Used to Understand $77B problemEmail This EntryPrint This Entry
Posted by Zack

Do you ever lose focus after working for several hours on a project? Are there times when you just can't seem to concentrate anymore? If you answered yes to these questions then you are probably normal. But what is normal? And for that matter what is attention deficit "hyperactivity" disorder, ADHD? According to the DSM, there are sixteen behavioral differences between the two groups.

In a recent Harvard study claimed that ADHD costs Americans suffering from the condition about $77 billion in lost income a year, more than the total costs of drug abuse or depression. Usually considered a childhood disorder, ADHD affects about 8 million U.S. adults and is linked to job loss, lower income, higher divorce rates and more driving accidents, said Dr. Joseph Biederman, professor of psychiatry at Harvard Medical School.

To help understand how the current set of attention focusing cogniceuticals impact normal brains versus those with ADHD, the NIMH recently approved a study that would give normal children and children with ADHD dextromethylphenadate and use neuroimaging techniques to see if there is a different response.

Since there are currently no biomarkers or neuroimaging tests that define ADHD from a neurological perspective, some argue that it doesn't exist. This new trial would add magnetic resonance images to map any differences in brain activation patterns, even though previous studies that attempted to use neuroimaging to define the disorder remain controversial.

While giving normal children these performance focusing cogniceuticals is causing a bit of an ethical stir, Judith Rapoport, chief of child psychology at NIMH, conducted a similar trial 20 years ago. The same stimulant was given to children at a higher dose. Researchers looked only at how the stimulant changed children's behavior as they performed tasks. The stimulant improved attention span in the children, regardless of whether they had ADHD. This time, I guess we'll see where specifically there might be a difference in brain activation between the groups and see if we can make a dent in this profoundly disruptive problem.


Category: Neuropharma


COMMENTS
chris on September 28, 2004 12:03 AM writes...

As somone diagnosed with ADD, I can vouch for the improved ability to concentrate through approprite medication. Another key element to my coping is a relentless search to understand my own personal flavor of the disorder and how various treatment may help.

One group that is at the forefront of this rearch is the amen clinic. I recommend the website, www.brainplace.org, to learn more and to view a vast catalog of brain images from a variety of diagnosis and how they compare to healthy brain scans.

The CHADD organization is another excellent resource. Their website is www.chadd.org.

Permalink to Comment


TRACKBACKS
TrackBack URL: http://www.corante.com/cgi-bin/mt/mt-tb.cgi/4706
ADHD - NeuroImaging Used to Understand $77B problem: Corante > Brain Waves > from RelentlesslyOptimistic ADHD - NeuroImaging Used to Understand $77B problem: Corante [Read More]

Tracked on November 28, 2004 09:54 AM




POST A COMMENT
Name:

Email:

URL:

Comments:

Remember personal info?



EMAIL THIS ENTRY TO A FRIEND
Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES